Literature DB >> 20170758

Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

Nicole M Iverson1, Sarah M Sparks, Bahar Demirdirek, Kathryn E Uhrich, Prabhas V Moghe.   

Abstract

A family of anionic nanoscale polymers based on amphiphilic macromolecules (AMs) was developed for controlled inhibition of highly oxidized low-density lipoprotein (hoxLDL) uptake by inflammatory macrophage cells, a process that triggers the escalation of a chronic arterial disease called atherosclerosis. The basic AM structure is composed of a hydrophobic portion formed from a mucic acid sugar backbone modified at the four hydroxyls with lauroyl groups conjugated to hydrophilic poly(ethylene glycol) (PEG). The AM structure-activity relationships were probed by synthesizing AMs with six key variables: length of the PEG chain, carboxylic acid location, type of anionic charge, number of anionic charges, rotational motion of the anionic group, and PEG architecture. All AM structures were confirmed by nuclear magnetic resonance spectroscopy and their ability to inhibit hoxLDL uptake in THP-1 human macrophage cells was compared in the absence and presence of serum. We report that AMs with one, rotationally restricted carboxylic acid within the hydrophobic portion of the polymer was sufficient to yield the most effective AM for inhibiting hoxLDL internalization by THP-1 human macrophage cells under serum-containing conditions. Further, increasing the number of charges and altering the PEG architecture in an effort to increase serum stabilization did not significantly impair the ability of AMs to inhibit hoxLDL internalization, suggesting that selected modifications to the AMs could potentially promote multifunctional characteristics of these nanoscale macromolecules. Copyright 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170758      PMCID: PMC2882988          DOI: 10.1016/j.actbio.2010.02.019

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  35 in total

Review 1.  Endothelial dysfunction, hemodynamic forces, and atherosclerosis.

Authors:  M A Gimbrone
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Novel amphiphilic macromolecules and their in vitro characterization as stabilized micellar drug delivery systems.

Authors:  Li Tao; Kathryn E Uhrich
Journal:  J Colloid Interface Sci       Date:  2006-01-05       Impact factor: 8.128

Review 3.  Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis.

Authors:  M P de Winther; K W van Dijk; L M Havekes; M H Hofker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

4.  Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages.

Authors:  Evangelia Chnari; Jessica S Nikitczuk; Jinzhong Wang; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomacromolecules       Date:  2006-06       Impact factor: 6.988

5.  Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).

Authors:  Alisar S Zahr; Cheryl A Davis; Michael V Pishko
Journal:  Langmuir       Date:  2006-09-12       Impact factor: 3.882

6.  Nanoscale anionic macromolecules for selective retention of low-density lipoproteins.

Authors:  Evangelia Chnari; Hamed B Lari; Lu Tian; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

7.  Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.

Authors:  Nicole M Plourde; Sandhya Kortagere; William Welsh; Prabhas V Moghe
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

8.  Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL.

Authors:  Evangelia Chnari; Jessica S Nikitczuk; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

9.  Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers.

Authors:  Y Tian; L Bromberg; S N Lin; T Alan Hatton; Kam C Tam
Journal:  J Control Release       Date:  2007-05-17       Impact factor: 9.776

10.  Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.

Authors:  Michelle N Bradley; Cynthia Hong; Mingyi Chen; Sean B Joseph; Damien C Wilpitz; Xuping Wang; Aldons J Lusis; Allan Collins; Willa A Hseuh; Jon L Collins; Rajendra K Tangirala; Peter Tontonoz
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

View more
  23 in total

1.  Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.

Authors:  Nicole M Iverson; Nicole M Plourde; Sarah M Sparks; Jinzhong Wang; Ekta N Patel; Pratik S Shah; Daniel R Lewis; Kyle R Zablocki; Gary B Nackman; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2011-08-03       Impact factor: 12.479

2.  Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.

Authors:  Neal K Bennett; Rebecca Chmielowski; Dalia S Abdelhamid; Jonathan J Faig; Nicola Francis; Jean Baum; Zhiping P Pang; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2016-10-04       Impact factor: 12.479

3.  Impact of ionizing radiation on physicochemical and biological properties of an amphiphilic macromolecule.

Authors:  Li Gu; Kyle Zablocki; Linda Lavelle; Stanko Bodnar; Frederick Halperin; Ike Harper; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Polym Degrad Stab       Date:  2012-06-27       Impact factor: 5.030

4.  Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.

Authors:  Dalia S Abdelhamid; Yingyue Zhang; Daniel R Lewis; Prabhas V Moghe; William J Welsh; Kathryn E Uhrich
Journal:  Biomaterials       Date:  2015-03-07       Impact factor: 12.479

5.  Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.

Authors:  Rebecca A Chmielowski; Dalia S Abdelhamid; Jonathan J Faig; Latrisha K Petersen; Carol R Gardner; Kathryn E Uhrich; Laurie B Joseph; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2017-05-15       Impact factor: 8.947

6.  Nanoscale amphiphilic macromolecules with variable lipophilicity and stereochemistry modulate inhibition of oxidized low-density lipoprotein uptake.

Authors:  Dawanne E Poree; Kyle Zablocki; Allison Faig; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2013-07-08       Impact factor: 6.988

7.  Efficient intracellular siRNA delivery by ethyleneimine-modified amphiphilic macromolecules.

Authors:  Sarah M Sparks; Carolyn L Waite; Alexander M Harmon; Leora M Nusblat; Charles M Roth; Kathryn E Uhrich
Journal:  Macromol Biosci       Date:  2011-07-26       Impact factor: 4.979

8.  Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.

Authors:  Sarah Hehir; Nicole M Plourde; Li Gu; Dawanne E Poree; William J Welsh; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Acta Biomater       Date:  2012-07-24       Impact factor: 8.947

9.  In silico design of anti-atherogenic biomaterials.

Authors:  Daniel R Lewis; Vladyslav Kholodovych; Michael D Tomasini; Dalia Abdelhamid; Latrisha K Petersen; William J Welsh; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2013-07-25       Impact factor: 12.479

10.  Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.

Authors:  Li Gu; Leora M Nusblat; Nasim Tishbi; Sarah C Noble; Chaya M Pinson; Evan Mintzer; Charles M Roth; Kathryn E Uhrich
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.